Valuation check: CCEL's PEG ratio is -20.8, below the Healthcare sector average of 11.64.
Get informed when a big investor buys or sells
+ Follow-20.80
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for CCEL is -20.8. That is below the Healthcare sector average of 11.64. Investors often review this figure alongside Cryo-Cell International's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, CCEL currently prints -20.8 for PEG ratio, while the sector average sits near 11.64. That is roughly 278.7% below the sector mean. Large gaps often invite a closer look at Cryo-Cell International's growth, margins, and balance sheet.
A PEG ratio of -20.8 for Cryo-Cell International is not 'good' or 'bad' on its own. Compare it with the peer average (11.64) and with CCEL's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting CCEL's PEG ratio (-20.8), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Cryo-Cell International's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.